{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-008698","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2022-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.269111+00:00","generated_at":"2026-06-26T11:23:40.218736+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Oncotelic announces JV agreement signing, press release and 8-K forthcoming","bullets":["Presented at MedInvest Pharmaceutical and Biotechnology Investor Conference on March 31, 2022.","Company stated a joint venture agreement is being signed; further disclosure via press release and 8-K.","No details on JV partner, terms, or timeline provided in the filing.","Presentation and recording available on company website and YouTube channel."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-008698","json":"https://secwatch.observer/filing/0001493152-22-008698.json","markdown":"https://secwatch.observer/filing/0001493152-22-008698.md","text":"https://secwatch.observer/filing/0001493152-22-008698.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315222008698/0001493152-22-008698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315222008698/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T11:23:40.218736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}